– Nuvaxovid™ de Novavax recibe la opinión positiva del CHMP para la autorización de comercialización completa para la prevención de la COVID en la UE GAITHERSBURG, Md., 29 de mayo de 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), una compañía global que promueve vacunas basadas en…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.